Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeting Orexin to Treat Nicotine Dependence
NCT03999099Phase 1Completed
- Sponsor
- McLean Hospital
- Start
- Sep 2019
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of suvorexant in nicotine dependence, sponsored by McLean Hospital. Started Sep 2019; status: completed.
02
Drugs
suvorexant
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03999099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999099.